How many stocks are there of Guerbet?
The current number of stocks of Guerbet is 12.64 M undefined.
Guerbet Stocks 2024
Guerbet Stocks
12.64 M
Ticker
GBT.PA
ISIN
FR0000032526
WKN
870481
In 2024, Guerbet had 12.64 M outstanding stocks, a 0% change from the 12.64 M stocks in the previous year.
The Guerbet Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2026e | 12.64 |
| 2025e | 12.64 |
| 2024e | 12.64 |
| 2023 | 12.64 |
| 2022 | 12.64 |
| 2021 | 12.64 |
| 2020 | 12.66 |
| 2019 | 12.67 |
| 2018 | 12.67 |
| 2017 | 12.67 |
| 2016 | 12.67 |
| 2015 | 12.54 |
| 2014 | 12.7 |
| 2013 | 12.7 |
| 2012 | 12.7 |
| 2011 | 13 |
| 2010 | 12.5 |
| 2009 | 12.6 |
| 2008 | 12.5 |
| 2007 | 12.6 |
| 2006 | 12.5 |
| 2005 | 12.6 |
| 2004 | 12.2 |
Guerbet shares outstanding FR0000032526 · 870481
The number of shares was Guerbet in 2023 — This indicates how many shares 12.641 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Guerbet earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Guerbet's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Guerbet’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Guerbet's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 12.2 M Aktien |
| 2005 | 12.6 M Aktien |
| 2006 | 12.5 M Aktien |
| 2007 | 12.6 M Aktien |
| 2008 | 12.5 M Aktien |
| 2009 | 12.6 M Aktien |
| 2010 | 12.5 M Aktien |
| 2011 | 13 M Aktien |
| 2012 | 12.7 M Aktien |
| 2013 | 12.7 M Aktien |
| 2014 | 12.7 M Aktien |
| 2015 | 12.54 M Aktien |
| 2016 | 12.67 M Aktien |
| 2017 | 12.67 M Aktien |
| 2018 | 12.67 M Aktien |
| 2019 | 12.67 M Aktien |
| 2020 | 12.66 M Aktien |
| 2021 | 12.64 M Aktien |
| 2022 | 12.64 M Aktien |
| 2023 | 12.64 M Aktien |
| 2024e | 12.64 M Aktien |
| 2025e | 12.64 M Aktien |
| 2026e | 12.64 M Aktien |
Guerbet Aktienanalyse
What does Guerbet do?
Guerbet SA is a global corporation specializing in medical imaging solutions. The company was founded in France in 1926 and is named after Marcel Guerbet, a chemist who developed the first iodine-based contrast agent for x-ray examination of blood vessels. Guerbet specializes in four main business areas: imaging solutions, X-ray contrast agents, interventional products, and diagnostic solutions. The portfolio includes contrast agents used in X-ray examinations as well as devices used in various medical imaging procedures such as CT or MRI. Guerbet's imaging solutions help doctors make accurate diagnoses and plan treatments. The X-ray contrast agent division is the heart of the company, and Guerbet is the second-largest provider of iodine-based X-ray contrast agents worldwide. Guerbet's interventional products are specifically designed for the minimally invasive treatment of conditions such as liver tumors. These include needles, catheters, and embolization materials. Guerbet's diagnostic solutions include various software solutions specialized in medical imaging and radiology. Guerbet is committed to constantly developing and improving its products and services. For example, the company has developed a new generation of contrast agents that are less toxic and gentler on the body. Guerbet is also working on the development of new minimally invasive techniques and materials in the field of interventions. Another important aspect of Guerbet's business philosophy is sustainability. The company actively promotes environmental protection and strives to make its products and services as environmentally friendly as possible. This includes the development of contrast agents that are biodegradable. Overall, Guerbet is a company specializing in medical imaging solutions and is characterized by continuous innovation and sustainability. The various divisions of the company work closely together to provide the best possible treatment for doctors and patients. Guerbet ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Guerbet's Shares Outstanding
Guerbet's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Guerbet’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Guerbet’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Guerbet’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Guerbet stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Guerbet are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Guerbet evolved in recent years?
The number of shares of Guerbet has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Guerbet as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Guerbet?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Guerbet pay?
Over the past 12 months, Guerbet paid a dividend of 1 EUR . This corresponds to a dividend yield of about 4.01 %. For the coming 12 months, Guerbet is expected to pay a dividend of 0.93 EUR.
What is the dividend yield of Guerbet?
The current dividend yield of Guerbet is 4.01 %.
When does Guerbet pay dividends?
Guerbet pays a quarterly dividend. This is distributed in the months of July, August, July, August.
How secure is the dividend of Guerbet?
Guerbet paid dividends every year for the past 23 years.
What is the dividend of Guerbet?
For the upcoming 12 months, dividends amounting to 0.93 EUR are expected. This corresponds to a dividend yield of 3.72 %.
In which sector is Guerbet located?
Guerbet is assigned to the 'Health' sector.
Wann musste ich die Aktien von Guerbet kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Guerbet from 7/3/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.
When did Guerbet pay the last dividend?
The last dividend was paid out on 7/3/2024.
What was the dividend of Guerbet in the year 2023?
In the year 2023, Guerbet distributed 1.7 EUR as dividends.
In which currency does Guerbet pay out the dividend?
The dividends of Guerbet are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Guerbet stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Guerbet
Our stock analysis for Guerbet Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Guerbet Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
